Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT)

Vincenzo Russo, Alberto Amadori, Marco Bregni, Luana Calabrò, Mario Paolo Colombo, Massimo Di Nicola, Pier Francesco Ferrucci, Enrico Proietti, Michele Maio, Matteo Bellone

Research output: Contribution to journalShort surveypeer-review


The explosion in the immuno-oncology field, exemplified by the clinical implementation of immune checkpoint inhibitor blockade and other immunotherapeutic strategies was quickly recognized by the Italian biomedical community, thanks to the networking activities of the Italian Network for Tumor Biotherapy (NIBIT), which has been active since 2004 in the diffusion of new scientific and clinical findings in the fields of tumor immunology and immunotherapy. Numerous activities of NIBIT have also helped to overcome the hurdles associated with the clinical implementation of cancer immune-biotherapeutic strategies at the national and international levels. Looking forward, a concerted interaction of NIBIT with existing European networks focused on cancer bio-immunotherapy will further contribute to the development of improved therapies in the immuno-oncology field. This Introduction briefly summarizes the history and objectives of NIBIT, as well as the current activities of the Network.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalCytokine and Growth Factor Reviews
Publication statusPublished - Aug 1 2017


  • biotherapy
  • cancer
  • immunotherapy
  • networks

ASJC Scopus subject areas

  • Immunology
  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT)'. Together they form a unique fingerprint.

Cite this